TVTX logo

Travere Therapeutics (TVTX) Gross Margin

Annual Gross Margin

92.12%
-3.84%-4.00%

December 31, 2023


Summary


Performance

TVTX Gross Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTVTXprofitabilitymetrics:

Quarterly Gross Margin

97.41%
+1.22%+1.27%

September 30, 2024


Summary


Performance

TVTX Quarterly Gross Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTVTXprofitabilitymetrics:

Gross Margin Formula

Gross Margin =  Gross Profit
Revenue
✕ 100%

TVTX Gross Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.0%+8.4%
3 y3 years-4.9%+0.4%
5 y5 years-4.7%+0.4%

TVTX Gross Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-5.1%at lowat high+12.5%
5 y5-year-5.1%at low-0.3%+12.5%
alltimeall time-6.0%at low-2.0%+12.5%

Travere Therapeutics Gross Margin History

DateAnnualQuarterly
Sep 2024
-
97.41%(+1.3%)
Jun 2024
-
96.19%(-0.2%)
Mar 2024
-
96.36%(+7.2%)
Dec 2023
92.12%(-4.0%)
89.87%(-6.9%)
Sep 2023
-
96.53%(+1.1%)
Jun 2023
-
95.49%(+10.3%)
Mar 2023
-
86.58%(-10.8%)
Dec 2022
95.96%(-1.2%)
97.04%(+1.1%)
Sep 2022
-
96.03%(-0.2%)
Jun 2022
-
96.21%(+0.6%)
Mar 2022
-
95.59%(-1.7%)
Dec 2021
97.10%(+0.2%)
97.21%(-0.5%)
Sep 2021
-
97.67%(+0.7%)
Jun 2021
-
96.98%(+0.5%)
Mar 2021
-
96.53%(+0.6%)
Dec 2020
96.91%(-0.1%)
95.94%(-1.8%)
Sep 2020
-
97.68%(+0.8%)
Jun 2020
-
96.92%(-0.2%)
Mar 2020
-
97.13%(+0.9%)
Dec 2019
97.01%
96.31%(-0.3%)
Sep 2019
-
96.59%(-1.2%)
DateAnnualQuarterly
Jun 2019
-
97.81%(+0.4%)
Mar 2019
-
97.43%(+1.1%)
Dec 2018
96.63%(-1.1%)
96.34%(-0.9%)
Sep 2018
-
97.22%(+0.1%)
Jun 2018
-
97.15%(+1.4%)
Mar 2018
-
95.80%(-1.5%)
Dec 2017
97.67%(+1.1%)
97.22%(-0.5%)
Sep 2017
-
97.71%(-0.2%)
Jun 2017
-
97.95%(+0.1%)
Mar 2017
-
97.89%(+1.1%)
Dec 2016
96.59%(-1.2%)
96.78%(+1.5%)
Sep 2016
-
95.37%(-1.6%)
Jun 2016
-
96.93%(-0.5%)
Mar 2016
-
97.39%(-0.1%)
Dec 2015
97.81%(-0.2%)
97.50%(-0.7%)
Sep 2015
-
98.17%(+0.8%)
Jun 2015
-
97.35%(-1.1%)
Mar 2015
-
98.42%(+0.8%)
Dec 2014
97.98%
97.60%(-0.0%)
Sep 2014
-
97.63%(-1.8%)
Jun 2014
-
99.39%(+2.7%)
Mar 2014
-
96.77%

FAQ

  • What is Travere Therapeutics annual gross profit margin?
  • What is the all time high annual gross margin for Travere Therapeutics?
  • What is Travere Therapeutics annual gross margin year-on-year change?
  • What is Travere Therapeutics quarterly gross profit margin?
  • What is the all time high quarterly gross margin for Travere Therapeutics?
  • What is Travere Therapeutics quarterly gross margin year-on-year change?

What is Travere Therapeutics annual gross profit margin?

The current annual gross margin of TVTX is 92.12%

What is the all time high annual gross margin for Travere Therapeutics?

Travere Therapeutics all-time high annual gross profit margin is 97.98%

What is Travere Therapeutics annual gross margin year-on-year change?

Over the past year, TVTX annual gross profit margin has changed by -3.84% (-4.00%)

What is Travere Therapeutics quarterly gross profit margin?

The current quarterly gross margin of TVTX is 97.41%

What is the all time high quarterly gross margin for Travere Therapeutics?

Travere Therapeutics all-time high quarterly gross profit margin is 99.39%

What is Travere Therapeutics quarterly gross margin year-on-year change?

Over the past year, TVTX quarterly gross profit margin has changed by +7.54% (+8.39%)